Skip to main content
SpringerLink
Log in

Naltrexone, smoking behaviour and cigarette withdrawal

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

In order to examine the role of endogenous opioids in the reinforcing effects of nicotine, a double-blind, placebo-controlled, cross-over design was used to study the effects of the opiate antagonist, naltrexone, on smoking behaviour and cigarette withdrawal in 12 heavy smokers. Although naltrexone (50 mg) appeared to reduce the perceived difficulty of abstaining during 24-h cigarette withdrawal, other withdrawal symptoms were unaffected. Naltrexone also had no effect on a variety of biochemical and behavioural measures of nicotine intake or on subjective satisfaction and enjoyment from the first cigarette smoked after 24-h abstinence. Similarly naltrexone (100 mg) had no effect on smoking behaviour, nicotine intake or satisfaction from smoking during a 48-h period of ad libitum smoking. However, during the ad libitum smoking period naltrexone caused mood changes of the kind that occur during tobacco withdrawal. Since nicotine intake and smoking behaviour were unaffected, the mood changes are unlikely to have been mediated by blockade or any other form of opioid interaction with nicotinic mechanisms. These findings provide evidence against the notion that the endogenous opioids are involved in mediating the reinforcing properties of nicotine in smokers under normal conditions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Altshuler HL, Phillips PE, Feinhandler DA (1980) Alteration of ethanol self-administration by naltrexone. Life Sci 26:679–688

    Google Scholar 

  • Ashton H (1992) Brain function and psychotropic drugs. Oxford University Press, Oxford

    Google Scholar 

  • Atkinson RL, Berke LK, Drake CR, Bibbs ML, Williams FL, Kaiser DL (1985) Effect of long-term therapy with naltrexone on body weight in obesity. Clin Pharmacol Ther 38:419–422

    Google Scholar 

  • Benwell MEM, Balfour DJK (1992) The effects of acute and repeated nicotine treatment on nucleus accumbens dopamine and locomotor activity. Br J Pharmacol 105:849–856

    Google Scholar 

  • Bond A, Lader M (1974) The use of analogue scales in rating subjective feelings. Br J Med Psychol 47:211–218

    Google Scholar 

  • Cohen MR, Cohen RM, Pickar D, Weingartner H, Murphy DL (1983) High-dose naloxone infusions in normals. Arch Gen Psychiatry 40:613–619

    Google Scholar 

  • Corrigall WA, Coen KM (1989) Nicotine maintains robust self-administration in rats on a limited-access schedule. Psychopharmacology 99:473–478

    Google Scholar 

  • Corrigall WA, Coen KM (1991a) Opiate antagonists reduce cocaine but not nicotine self-administration. Psychopharmacology 104:167–170

    Google Scholar 

  • Corrigall WA, Coen KM (1991b) Selective dopamine antagonists reduce nicotine self-administration. Psychopharmacology 104:171–176

    Google Scholar 

  • Corrigall WA, Franklin KBJ, Coen KM, Clarke PBS (1992) The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology 107:285–289

    Google Scholar 

  • De Vry J, Donselaar I, Van Ree JM (1989) Food deprivation and acquisition of intravenous cocaine self-administration in rats: effect of naltrexone and haloperidol. Pharmacol Exp Ther 251:735–740

    Google Scholar 

  • Dawe S, Gerada C, Russell MAH, Gray JA (1995) Nicotine intake in smokers increases following a single dose of haloperidol. Psychopharmacology 117:110–115

    Google Scholar 

  • Dollery CT (ed) (1991) Therapeutic drugs vol. 2. Churchill Livingstone, Edinburgh, UK

    Google Scholar 

  • Feyerabend C, Russell MAH (1990) A rapid gas-liquid chromatographic method for the determination of continine and nicotine in biological fluids. J Pharm Pharmacol 42:450–452

    Google Scholar 

  • Fuxe K, Andersson K, Härfstrand A, Eneroth P, de la Mora MP, Agnati LF (1990) Effects of nicotine on synaptic transmission in the brain. In: Wonnacott S, Russell MAH, Stolerman IP (eds) Nicotine psychopharmacology: molecular, cellular, and behavioural aspects. Oxford University Press, Oxford, pp 194–225

    Google Scholar 

  • Gorelick DA, Rose J, Jarvik ME (1989) Effect of naloxone on cigarette smoking, J Subst Abuse 1:153–159

    Google Scholar 

  • Grenhoff J, Ashton-Jones G, Svensson TH (1986) Nicotine effects on the firing pattern of midbrain dopamine neurons. Acta Physiol Scand 128:351–358

    Google Scholar 

  • Gross J, Stitzer ML (1989) Nicotine replacement: ten-week effects on tobacco withdrawal symptoms. Psychopharmacology 98:334–341

    Google Scholar 

  • Hatsukami DK, Mitchell JE, Morley JE, Morgan SF, Levine AS (1986) Effect of naltrexone on mood and cognitive functioning among overweight men. Biol Psychiatry 21:293–300

    Google Scholar 

  • Hollister LE, Johnson K, Boukhabza D, Gillespie HK (1981) Aversive effects of naltrexone in subjects not dependent on opiates. Drug Alcohol Depend 8:37–41

    Google Scholar 

  • Hughes JR, Hatsukami DK (1986) Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry 43:289–294

    Google Scholar 

  • Jones B, Kenward MG (1989) Design and analysis of cross-over trials. Monographs on statistics and applied probability no. 34. Chapman and Hall, London

    Google Scholar 

  • Karras A, Kane J (1980) Naloxone reduces cigarette smoking. Life Sci 27:1541–1545

    Google Scholar 

  • Kornet M, Goosen C, Van Ree JM (1991) Effect of naltrexone on alcohol consumption during chronic alcohol drinking and after a period of imposed abstinence in free-choice drinking rhesus monkeys. Psychopharmacology 104:367–376

    Google Scholar 

  • McFall RM, Hammen CL (1971) Motivation, structure, and self-monitoring: role of non-specific factors in smoking reduction. J Consult Clin Psychol 37:80–86

    Google Scholar 

  • Mendelson JH, Ellingboe J, Keuhnle JC, Mello NK (1979) Effects of naltrexone on mood and neuroendocrine function in normal adult males. Psychoneuroendocrinology 3:231–236

    Google Scholar 

  • Nemeth-Coslett R, Griffiths RR (1986) Naloxone does not affect cigarette smoking. Psychopharmacology 89:261–264

    Google Scholar 

  • Nemeth-Coslett R, Henningfield JE, O'Keefe MK, Griffiths RR (1986) Effects of mecamylamine on human cigarette smoking and subjective ratings. Psychopharmacology 88:420–425

    Google Scholar 

  • O'Malley SS, Jaffe AJ, Chang G, Schottenfeld RS, Meyer RE, Rounsaville B (1992) Naltrexone and coping skills therapy for alcohol dependence; a controlled study. Arch Gen Psychiatry 49:881–887

    Google Scholar 

  • Optiz K, Weischer ML (1988) Volitional oral intake of nicotine in tupaias: drug-induced alterations. Drug Alcohol Depend 21:99–104

    Google Scholar 

  • Palmer RF, Berens A (1983) Double-blind study of the effect of naloxone on the pleasure of smoking. Fed Proc 42:654

    Google Scholar 

  • Pomerleau CS, Pomerleau OF, Majchrzak MJ (1987) Mecamylamine pre-treatment increases subsequent nicotine self-administration as indicated by changes in plasma nicotine level. Psychopharmacology 9:391–393

    Google Scholar 

  • Russell MAH, Armstrong E, Patel UA (1976) Temporal contiguity in electric aversion therapy for cigarette smoking. Behav Res Ther 14:103–123

    Google Scholar 

  • Seyler LE, Pomerleau OF, Fertig JB, Hunt D, Parker K (1986) Pituitary hormone response to cigarette smoking. Pharmacol Biochem Behav 24:159–162

    Google Scholar 

  • Spealman RD, Goldberg RD (1982) Maintenance of schedule-controlled behaviour by intravenous injections of nicotine in squirrel monkeys. J Pharmacol Exp Ther 223:402–408

    Google Scholar 

  • Stalke J, Hader O, Hensen J, Bahr V, Scherer G, Oelkers W (1991) Nicotine infusion in man stimulates plasma vasopressin, ACTH and cortisol. In: Adkofer F, Thuran K (eds) Effects of nicotine in biological systems. Birkhauser Verlag, Basel, pp 339–343

    Google Scholar 

  • Stapleton JA, Russell MAH, Feyerabend C, Wiseman SM, Gustavsson G, Säwe U (1995) Dose effects and predictors of outcome in a randomized trial of transdermal nicotine patches in general practice. Addiction 90:31–42

    Google Scholar 

  • Sternbach HA, Annitto W, Pottash ACL, Gold MS (1982) Anorexic effects of naltrexone in man. Lancet 1:388–389

    Google Scholar 

  • Stolerman IP, Goldfarb T, Fink R, Jarvik ME (1973) Influencing cigarette smoking with nicotine antagonists. Psychopharmacologia 28:247–259

    Google Scholar 

  • Trenchard E, Silverstone T (1983) Naloxone reduces the food intake of normal human volunteers. Appetite 4:43–50

    Google Scholar 

  • Volpicelli JR, Alterman AI, Hayashida M, O'Brien CP (1992) Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 49:876–880

    Google Scholar 

  • West RJ, Russell MAH (1987) Cardiovascular and subjective effects of smoking before and after 24 h of abstinence from cigarettes. Psychopharmacology 92:118–121

    Google Scholar 

  • West RJ, Jarvis MJ, Russell MAH, Carruthers ME, Feyerabend C (1984) Effect of nicotine replacement on the cigarette withdrawal syndrome. Br J Addict 79:215–219

    Google Scholar 

  • West RJ, Hajek P, Belcher M (1987) Time course of cigarette withdrawal symptoms during four weeks of treatment with nicotine chewing gum. Addict Behav 12:199–203

    Google Scholar 

  • West RJ, Hajek P, McNeill A (1991) Effect of buspirone on cigarette withdrawal symptoms and short-term abstinence rates in a smokers clinic. Psychopharmacology 104:91–96

    Google Scholar 

  • Wonnacott S (1989) Functional studies of brain nicotine receptors. (1989) In: Nordberg A, Fuxe K, Holmstedt B, Sundwall A (eds) Progress in brain research, vol. 79. Elsevier, Amsterdam

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Health Behaviour Unit, Institute of Psychiatry, SE5 8AF, London, UK

    G. Sutherland, J. A. Stapleton & M. A. H. Russell

  2. Poisons Unit, New Cross Hospital, SE14, London, UK

    C. Feyerabend

Authors
  1. G. Sutherland
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. A. Stapleton
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. A. H. Russell
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. Feyerabend
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sutherland, G., Stapleton, J.A., Russell, M.A.H. et al. Naltrexone, smoking behaviour and cigarette withdrawal. Psychopharmacology 120, 418–425 (1995). https://doi.org/10.1007/BF02245813

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02245813

Key words

Search

Navigation